Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$1.06 - $1.67 $1.33 Million - $2.09 Million
1,253,202 Added 208.35%
1,854,703 $2.15 Million
Q4 2023

Feb 13, 2024

BUY
$1.26 - $1.79 $657,869 - $934,593
522,119 Added 657.73%
601,501 $1.02 Million
Q3 2023

Nov 14, 2023

BUY
$1.61 - $2.54 $103,466 - $163,233
64,265 Added 425.12%
79,382 $143,000
Q2 2023

Aug 09, 2023

SELL
$1.14 - $1.95 $606 - $1,037
-532 Reduced 3.4%
15,117 $28,000
Q1 2023

May 15, 2023

SELL
$1.2 - $2.19 $20,115 - $36,710
-16,763 Reduced 51.72%
15,649 $20,000
Q4 2022

Feb 14, 2023

BUY
$1.63 - $3.52 $52,831 - $114,090
32,412 New
32,412 $54,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $9.25B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Cetera Advisor Networks LLC Portfolio

Follow Cetera Advisor Networks LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisor Networks LLC with notifications on news.